Support our Foundation of Myology project
The Institute teams at the 23rd JSFM, 18–20 November 2026 in Montpellier
Partager sur
The 23rd Annual Conference of the French Society of Myology will take place from 18 to 20 November 2026 in Montpellier. The conference brings together experts, researchers and clinicians to share the latest scientific and clinical advances in this field.
Oral presentations and sessions moderated by experts from the Institute of Myology
▻ Wednesday 18 November
11h00 – 13h00 – SFM/FILNEMUS joint teaching session
Chairmen : Capucine Trollet, Paris & Pascal Cintas, Toulouse
- Tanya Stojkovic – A la frontière du muscle et du nerf : les chevauchements génétiques
- Fiorella-Carla Grandi – Epigenetic Regulation of Gene Expression: Effects and Consequences for Neuromuscular Health and Disease
15h00 – 16h00 – Symposium UCB – Diagnosis and management of mitochondrial neuromuscular disorders
- Gorka Fernández-Eulate – Complications respiratoires dans les myopathies mitochondriales
15h00 – 16h00 – Fundamental session 1
- Eline Lemerle – Dystrophin controls clathrin‑mediated endocytosis and endolysosomal homeostasis
▻ Thursday 19 November
14h00 – 16h00 – Plenary session 2 – Technological advances in genetics for the diagnosis and prognosis of neuromuscular diseases
- Stéphanie Tomé – Séquençage long reads pour caractérisation des répétitions dans la maladie de Steinert
16h00 – 16h45 – Presentation of the 2025 SFM Awards
- Prix master 2024 : Dimitrios Kourtzas
- Prix impulsion 2025 : Pierre Klein
▻ Friday 20 November
09h00 – 10h30 – Plenary session 4 – Pathologies associated with RYR1 defects
Chairmen : Clément Hersent, Montpellier & Stéphane Vassilopoulos, Paris
11h00 – 12h00 Fundamental session 4
- Louise Benarroch – LAMA2-related Muscular Dystrophy: How Nonsense-Associated Alternative Splicing Offers Cellular Protection
12h00 – 13h00 – Clinical session 2 – Muscle manifestations of multisystemic proteinopathies
- Béatrice Labella – Caractérisation du spectre histopathologique des myosites associées aux inhibiteurs de checkpoint immunitaire : développement et validation d’un score diagnostique
- Marion Masingue – Une Myasthénie du sujet âgé
12h00 – 13h00 – Fundamental session 5
- Marine Leconte – DNAmacromolécule complexe, l’ADN est le support de l’hérédité (gènes). C’est le constituant des chromosomes. L’ADN est organisé en double hélice (deux brins complémentaires) et constitué de nucléotides de quatre types : adénine, guanine, cytosine et thymine. damage in LMNA-related congenital muscular dystrophy
